Wird geladen...
Exposure‐Response (Efficacy) Analysis of Daclatasvir and Asunaprevir in Japanese Patients With Hepatitis C Virus Infection
The treatment of hepatitis C virus (HCV) infection has been revolutionized by the development of all‐oral combination regimens of direct‐acting antiviral agents. The current analysis characterized the relationship between exposures of daclatasvir (DCV; tablets) and asunaprevir (ASV; capsules) and su...
Gespeichert in:
| Veröffentlicht in: | J Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175176/ https://ncbi.nlm.nih.gov/pubmed/30063245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1262 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|